Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation

Erythropoietin (EPO) has beneficial effects on glucose metabolism and insulin resistance. However, the mechanism underlying these effects has not yet been elucidated. This study aimed to investigate how EPO affects hepatic glucose metabolism. Here, we report that EPO administration promoted phosphat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Zhijuan, Zhang, Pengzi, Hong, Ting, Tang, Sunyinyan, Meng, Ran, Bi, Yan, Zhu, Dalong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672330/
https://www.ncbi.nlm.nih.gov/pubmed/26643367
http://dx.doi.org/10.1038/srep17878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672330/
https://www.ncbi.nlm.nih.gov/pubmed/26643367
http://dx.doi.org/10.1038/srep17878

Ejemplares similares